• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Arstasis

edit

Arstasis, Inc., headquartered in Redwood City, California, is a medical device manufacturer dedicated to bringing innovative access devices to cardiologists, interventional radiologists, their staffs, and patients. The company’s lead product, the AXERA Access Device, was launched in the U.S. in April 2011. The device is used in the Arstaotomyâ„¢ procedure, a new way to gain access to the femoral artery that some physicians believe results in a more pleasant and efficient cath lab and post-procedure experience for clinician and patient alike.

Recent Milestones

edit

• 
  Arstasis received $12M in Series E funding. (6/26/12)
  Posted 6/26/12 at 6:55pm via dowjones.com
• 
  Arstasis added Rami Elghandour as Board of Directors. (5/1/12)
  Posted 4/23/13 at 1:24pm
• 
  Arstasis received $25.5M in Series E funding. (5/31/11)
  Posted 6/8/11 at 7:49pm via arstasis.com
• 
  Arstasis added Alex Arrow as CFO.
  Posted 6/8/11 at 7:49pm
• 
  Arstasis added D. Bruce Modesitt as Founder, President, and CEO.
  Posted 6/8/11 at 7:49pm

Videos

Screenshots

edit

Sources

1. ARSTASIS CLOSES $25.5 MILLION SERIES E FINANCING (arstasis.com) [edit]
2. Arstasis Raises $12M More from Insiders, Plans Wider Rollout of Medical Device (pevc.dowjones.com) [edit]